Epogen Pediatric Use & Neupogen Cable Ads Expand Major Amgen Franchises
Executive Summary
New cable TV ads to identify new cancer patients for Neupogen and a recently approved expansion of Epogen indications to the pediatric population are examples of Amgen's increasing efforts to support its flagship franchises.
You may also be interested in...
FDAMA Pediatric Incentives Should Apply To Biologics, PhRMA Testifies
FDA may be willing to discuss new incentives for manufacturers to conduct pediatric studies on products not covered under the FDA Modernization Act's pediatric exclusivity rule, FDA Commissioner Henney said Oct. 21 at a hearing of the Senate Health, Education, Labor & Pensions Committee.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials